Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950134-03-004081
Filing Date
2003-03-18
Accepted
2003-03-18 11:31:11
Documents
2
Group Members
DAVID EINHORN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G d04110isc13gza.txt SC 13G/A 10617
3 JOINT FILING AGREEMENT d04110iexv1.txt EX-1 1757
  Complete submission text file 0000950134-03-004081.txt   14582
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49690 | Film No.: 03607213
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 420 LEXINGTON AVENUE SUITE 875 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 875 NEW YORK NY 10170 2129731900
GREENLIGHT CAPITAL LLC (Filed by) CIK: 0001040272 (see all company filings)

EIN.: 133886851 | State of Incorp.: DE | Fiscal Year End: 1231